0
Get Alert
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

Articles   |    
Short-Term Improvement in Schizophrenia: The Contribution of Background Factors
THE NATIONAL INSTITUTE OF MENTAL HEALTH PSYCHOPHARMACOLOGY RESEARCH BRANCH COLLABORATIVE STUDY GROUP
Am J Psychiatry 1968;124:900-909.
View Author and Article Information

1967-68, American Psychiatric Association

text A A A
PDF of the full text article.
Abstract

Three categories of background factors were found to predict short-term improvement (symptom reduction) in schizophrenic patients receiving either placebo or one of three phenothiazines: general predictors, which applied equally to all treatments; predictors of outcome under placebo but not under drug treatment, or vice versa; and predictors of outcome under one phenothiazine but not another. Some variables found by other investigators to predict outcome were not found to be predictors in this study; it is suggested that these variables are not related to the specific outcome measure of symptom reduction.

Abstract Teaser
Figures in this Article

Your Session has timed out. Please sign back in to continue.
Sign In Your Session has timed out. Please sign back in to continue.
Sign In to Access Full Content
 
Username
Password
Sign in via Athens (What is this?)
Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.
Not a subscriber?

Subscribe Now/Learn More

PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

+

References

+
+

CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of APA editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe



Related Content
Articles
Books
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 12.  >
The American Psychiatric Publishing Textbook of Psychiatry, 5th Edition > Chapter 6.  >
The American Psychiatric Publishing Textbook of Psychiatry, 5th Edition > Chapter 10.  >
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 1.  >
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 2.  >
Topic Collections
Psychiatric News
Read more at Psychiatric News >>
APA Guidelines
PubMed Articles
Pericyazine for schizophrenia. Cochrane Database Syst Rev 2014;5():CD007479.